Publications by authors named "Chunxuan Lin"

Claim this Profile
N
Necroptosis-related lncRNAs: biomarkers for predicting prognosis and immune response in lung adenocarcinoma.
Chunxuan Lin, Kunpeng Lin, Xiaochun Lin, Hai Yuan, Yingying Zhang

Transl Lung Cancer Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A genomic instability-associated lncRNA signature for predicting prognosis and biomarkers in lung adenocarcinoma.
Chunxuan Lin, Kunpeng Lin, Pan Li, Hai Yuan, Xiaochun Lin

Sci Rep· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Characterization Clinical and Immunotherapeutic Characteristics of m5C Regulator NOP2 Across 33 Cancer Types.
Taisheng Liu, Jian Zhang, Chunxuan Lin, Guihong Liu, Guofeng Xie

Front Cell Dev Biol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5-methylcytosine RNA methylation regulators affect prognosis and tumor microenvironment in lung adenocarcinoma.
Taisheng Liu, Xiaoshan Hu, Chunxuan Lin, Xiaoshun Shi, Yujing He

Ann Transl Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LKB1 expression and the prognosis of lung cancer: A meta-analysis.
Chunxuan Lin, Xiaochun Lin, Kunpeng Lin, Jialiang Tan, Chenggong Wei

Medicine (Baltimore)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and clinicopathological value of PD-L2 in lung cancer: A meta-analysis.
Xiaochun Lin, Kunpeng Lin, Chunxuan Lin, Taisheng Liu, Mingchen Ba

Int Immunopharmacol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and clinicopathological utility of PD-L2 expression in patients with digestive system cancers: A meta-analysis.
Xiaochun Lin, Kunpeng Lin, Chunxuan Lin, Jiakang Wang, Yunqiang Tang

Int Immunopharmacol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis